SHENOUDA MAGED purchased 173.4% of their position (500K shares) of RELMADA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $1.10M — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 11/6/2025ACC: 0001213900-25-106836
+500K
Net shares
Net buyer
$1.10M
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
500K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+500K
Price / share
$2.20
Trade value
$1.10M
% of position
173.4%
11/5/2025
288.33K→788.34K
Total
Net shares
+500K
Net value
$1.10M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/5/2025 | P · Purchase | +500K | $2.20 | $1.10M | 173.4% | 288.33K | 788.34K |
| Total | +500K | $1.10M | ||||||
Derivative Transactions0
No derivative transactions reported